以腹腔鏡輸尿管剝離術治療後腹腔纖維化併尿路阻塞病變
台北市立聯合醫院醫院經驗報告
賴昱維1,2 、薛又仁1,2、 黃建榮1, 2 、邱逸淳1,2 、陳修聖1,2、 邱文祥1,2
台北市立聯合醫院外科部泌尿外科1
國立陽明大學醫學院泌尿學科2
Laparoscopic ureterolysis in patients with retroperitoneal fibrosis and obstructive uropathy: taipei city hospital experience.
Yu-Wei Lai、Thomas Y. Hsueh、Andy C. Huang、Yi-Chun Chiu、Shiou-Sheng Chen、Allen W. Chiu
Divisions of Urology, Department of Surgery, Taipei City Hospital, Taiwan1
National Yang-Ming University, School of Medicine, Taiwan2
 
Purpose: To analyze the outcomes of laparoscopic ureterolysis (LU) in retroperitoneal fibrosis (RPF) with obstructive uropathy.
PATIENTS AND METHODS:
Records of 5 patients with RPF who had obstructive uropathy at presentation and had undergone LU at our hospital during January 2010 to Decemberb 2014 were collected and analyzed.
RESULTS:
Two females and three males underwent LU for RPF. Underlying causes of RPF could not be found in 1 (20%) cases. All patients underwent sigle side LU. Mean operative time and estimated blood loss were 78 minutes (range, 45-125 minutes) and 180 mL (range, 60-400 mL), respectively. No case required conversion to open surgery. No significant intraoperative complication (0/5 [0%]) was noted. Only one patient (1/5 [20%])  need blood transfusion because intraoperative bleeding . The postoperative complication rate was 0% (0/5). Most complications were minor and did not need specific treatment. The mean follow-up period was 20 months (range, 6-45 months). The success rate at last follow-up was 100%. After operation, no patient had obstructive uropathy and symptomatic flank pain.
CONCLUSIONS:
Treatment of RPF is still controversial. Laparoscopic ureterollysis to treat obstructive uropathy because of retroperitonal fibrosis is safe, feasible and effective
    位置
    資料夾名稱
    摘要
    發表人
    TUA秘書處1
    單位
    台灣泌尿科醫學會
    標籤
    非討論式海報
    建立
    2015-06-04 22:56:00
    最近修訂
    2015-06-04 23:01:00
    瀏覽
    1,331
    more